Skip to main content
Fresenius Medical Care AG & Co. KGaA logo

Fresenius Medical Care AG & Co. KGaA — Investor Relations & Filings

Ticker · FME ISIN · DE0005785802 LEI · 549300CP8NY40UP89Q40 F Human health and social work activities
Open in API
Filings indexed 1,534 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country DE Germany
Listing F FME

About Fresenius Medical Care AG & Co. KGaA

https://www.freseniusmedicalcare.com/en…

Fresenius Medical Care is a leading global provider of products and services for individuals with renal diseases. The company delivers comprehensive dialysis care to patients with chronic kidney failure through an extensive network of outpatient clinics. Its core services include in-center hemodialysis, home hemodialysis (HHD), and peritoneal dialysis (PD). As a vertically integrated company, it also develops, manufactures, and distributes a wide array of products essential for kidney replacement therapy. This portfolio includes advanced dialysis machines, dialyzers, water treatment systems, and related disposables. The company's offerings extend to home therapy systems, critical care solutions for acute blood purification and therapeutic apheresis, and specialized pediatric dialysis treatments.

Recent filings

Filing Released Lang Actions
: Release of a capital market information
Regulatory Filings
2026-05-04 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a regulatory announcement disclosing the periodic progress of Fresenius Medical Care AG’s share buyback program, including detailed tables of shares purchased by date and volume. This is a direct report of the company buying back its own shares, which falls under the “Transaction in Own Shares” category.
2026-04-27 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a regulatory disclosure under EU market abuse regulation detailing the number of shares repurchased by Fresenius Medical Care AG over a specified period, including transaction dates, quantities, prices, and trading venues. This fits the definition of a company buying back its own shares, which falls under “Transaction in Own Shares.”
2026-04-20 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a regulatory announcement under EU Market Abuse Regulation disclosing details of Fresenius Medical Care AG’s share buyback programme, including volumes bought back and trading venues. This falls squarely under a report of transactions in the company’s own shares (share repurchase), matching the “Transaction in Own Shares” category.
2026-04-13 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a regulatory announcement detailing Fresenius Medical Care AG’s share buyback activity over a specific period. It enumerates the number of shares repurchased, weighted average prices, volumes, and trading venues under the second tranche of its share buyback program. This clearly constitutes a report on the company’s transactions in its own shares. Therefore, the correct classification is Transaction in Own Shares (POS).
2026-04-07 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a regulatory announcement under EU MAR (Art. 5 para. 1 lit. b) detailing the interim results of a share buyback program, including the number of shares repurchased, prices, volumes, and trading venues. This clearly falls under the “Transaction in Own Shares” category, which covers share repurchase reports.
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.